Zhongxing BioTech plans to invest approximately 700 million yuan to build a southwestern headquarters base for the food and medicinal mushroom industry to improve its business layout
I'm LongbridgeAI, I can summarize articles.Zhongxing BioTech plans to invest approximately 700 million RMB to build a southwest headquarters base for the edible and medicinal mushroom industry park in Jintang County. The project is divided into two phases, with the first phase involving an investment of about 500 million RMB, focusing on the research and cultivation of rare edible and medicinal mushrooms such as Cordyceps sinensis. The second phase will invest approximately 200 million RMB, mainly for industrial improvement and supporting facilities. This move will help enhance the company's business layout and overall competitiveness
According to the Zhitong Finance APP, Zhongxing BioTech (002772.SZ) announced that the company plans to sign a project investment agreement and a project investment supplementary agreement with the People's Government of Jintang County and the Jintang County Tianfu Mushroom Capital Agricultural Industrial Park Management Committee designated by the People's Government of Jintang County. The company intends to invest in the establishment of a Southwest headquarters base project for the edible and medicinal mushroom industry, with a total project investment of approximately 700 million RMB, of which the first phase of the project will invest about 500 million RMB (including fixed asset investment of 200 million RMB). The project will adopt a leasing model, leasing the Phase III project carrier of the Jintang County Tianfu Mushroom Capital Agricultural Industrial Park, including standardized industrial plants of approximately 105,000 m2 and neighborhood center buildings of approximately 54,000 m2. Some of the plants will be upgraded and transformed based on the original buildings, focusing on the industrialized bionic cultivation project of Cordyceps sinensis, as well as the research and cultivation of other rare edible and medicinal mushrooms, and the establishment of a research and development center for edible and medicinal mushrooms and health-oriented specialty agricultural products, intelligent production workshops, etc. The second phase of the project will invest approximately 200 million RMB (including fixed asset investment of 50 million RMB), intending to purchase 50 acres of land, mainly to improve and support the industry around the first phase project. The company plans to establish a wholly-owned subsidiary, Sichuan Zhongxing BioTech Co., Ltd. (tentative name, subject to the information approved and registered by the market supervision and management department), specifically responsible for implementing the project. After the establishment of the wholly-owned subsidiary, a leasing agreement will be signed.
It is reported that implementing this investment will help improve the company's business layout, expand business development space, enhance the company's overall competitiveness, and meet the company's strategic development plan and market demand